Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
EW US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Edwards Lifesciences Corporation
(EW US)
$107.15
+1.35
1.28%
(Market Closed · 21:00:02 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
EDINET Filings
Financials
Charting
Short Interest
Employees
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
EW US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Edwards Lifesciences Corporation
(EW US)
$107.15
+1.35
1.28%
(Market Closed · 21:00:02 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
EDINET Filings
Financials
Charting
Short Interest
Employees
Chronological
By Owner
EDINET Filings
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological
By Owner
EDINET Filings
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological SEC Filings
Chronological SEC Filings
Select Filings
Non-Ownership Filings
(467)
Expand
10-Q
Q3
ended 30 Sept 2026
4 Nov
8-K
Results of Operations and Financial Condition
4 Nov
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
28 Aug
S-8
Registration statement (employee benefit plan)
4 Aug
10-Q
Q2
ended 30 Jun 2026
4 Aug
8-K
Results of Operations and Financial Condition
23 Jul
SD
SD
27 May
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
8 May
10-Q
Q1
ended 31 Mar 2026
6 May
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
4 May
8-K
Results of Operations and Financial Condition
23 Apr
DEFA14A
Definitive additional materials
26 Mar
ARS
Annual report to security holders
26 Mar
DEFA14A
Definitive additional materials
26 Mar
DEF 14A
Definitive proxy statement
26 Mar
10-K
FY 2025
ended 31 Dec 2025
25 Feb
8-K
Results of Operations and Financial Condition
10 Feb
8-K
Regulation FD Disclosure
9 Jan
10-Q
Q3
ended 30 Sept 2025
5 Nov 2025
8-K
Edwards Lifesciences CorporationOne Edwards Way · Irvine, CA USA · 92614Phone: 949.250.2500 · www.edwards.com
30 Oct 2025
Ownership Filings
(2.1K)
Expand
Form 4
Dahl Andrew M.
08:21PM
Form 4
Lippis Daniel J.
10 Nov
Form 144
Lippis Daniel J.
10 Nov
Form 4
Zovighian Bernard J
9 Nov
Form 4
BOBO DONALD E JR
9 Nov
Form 144
Zovighian Bernard J
9 Nov
Form 144
BOBO DONALD E JR
9 Nov
Form 4
Lippis Daniel J.
8 Oct
Form 4
Markowitz Wayne
14 Sep
Form 4
Dahl Andrew M.
14 Sep
Form 4
Chopra Daveen
11 Sep
Form 4
Lippis Daniel J.
11 Sep
Form 4
Dahl Andrew M.
31 Aug
Form 144
Dahl Andrew M.
31 Aug
Form 4
Bruls Annette
28 Aug
Form 144
Bruls Annette
28 Aug
Form 4
Chopra Daveen
26 Aug
Form 4
Markowitz Wayne
26 Aug
Form 144
Markowitz Wayne
26 Aug
Form 144
Chopra Daveen
26 Aug
Select Filings
Non-Ownership Filings
(467)
Expand
10-Q
Q3
ended 30 Sept 2026
4 Nov
8-K
Results of Operations and Financial Condition
4 Nov
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
28 Aug
S-8
Registration statement (employee benefit plan)
4 Aug
10-Q
Q2
ended 30 Jun 2026
4 Aug
8-K
Results of Operations and Financial Condition
23 Jul
SD
SD
27 May
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
8 May
10-Q
Q1
ended 31 Mar 2026
6 May
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
4 May
8-K
Results of Operations and Financial Condition
23 Apr
DEFA14A
Definitive additional materials
26 Mar
ARS
Annual report to security holders
26 Mar
DEFA14A
Definitive additional materials
26 Mar
DEF 14A
Definitive proxy statement
26 Mar
10-K
FY 2025
ended 31 Dec 2025
25 Feb
8-K
Results of Operations and Financial Condition
10 Feb
8-K
Regulation FD Disclosure
9 Jan
10-Q
Q3
ended 30 Sept 2025
5 Nov 2025
8-K
Edwards Lifesciences CorporationOne Edwards Way · Irvine, CA USA · 92614Phone: 949.250.2500 · www.edwards.com
30 Oct 2025
Ownership Filings
(2.1K)
Expand
Form 4
Dahl Andrew M.
08:21PM
Form 4
Lippis Daniel J.
10 Nov
Form 144
Lippis Daniel J.
10 Nov
Form 4
Zovighian Bernard J
9 Nov
Form 4
BOBO DONALD E JR
9 Nov
Form 144
Zovighian Bernard J
9 Nov
Form 144
BOBO DONALD E JR
9 Nov
Form 4
Lippis Daniel J.
8 Oct
Form 4
Markowitz Wayne
14 Sep
Form 4
Dahl Andrew M.
14 Sep
Form 4
Chopra Daveen
11 Sep
Form 4
Lippis Daniel J.
11 Sep
Form 4
Dahl Andrew M.
31 Aug
Form 144
Dahl Andrew M.
31 Aug
Form 4
Bruls Annette
28 Aug
Form 144
Bruls Annette
28 Aug
Form 4
Chopra Daveen
26 Aug
Form 4
Markowitz Wayne
26 Aug
Form 144
Markowitz Wayne
26 Aug
Form 144
Chopra Daveen
26 Aug
Ask in Filing
Ask in Filing
